Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Caphosol® Artifical Saliva (32 doses sachet box)

K-Number: K234015 · 2024-03-11

Decision Date2024-03-11
Product CodeLFD
DecisionSubstantially Equivalent

Device Summary

Caphosol® Artifical Saliva (32 doses sachet box) is a medical device manufactured by Eusa Pharma (Uk) Limited. It received FDA 510(k) clearance on 2024-03-11 under approval number K234015. The device is classified under product code LFD. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Caphosol® Artifical Saliva (32 doses sachet box)?

Caphosol® Artifical Saliva (32 doses sachet box) is a medical device that received FDA 510(k) clearance on 2024-03-11. It is manufactured by Eusa Pharma (Uk) Limited. The 510(k) number is K234015.

When was Caphosol® Artifical Saliva (32 doses sachet box) approved by the FDA?

Caphosol® Artifical Saliva (32 doses sachet box) received FDA 510(k) clearance on 2024-03-11, under approval number K234015.

What company makes Caphosol® Artifical Saliva (32 doses sachet box)?

Caphosol® Artifical Saliva (32 doses sachet box) is manufactured by Eusa Pharma (Uk) Limited.

What is the FDA product code for Caphosol® Artifical Saliva (32 doses sachet box)?

The FDA product code for Caphosol® Artifical Saliva (32 doses sachet box) is LFD.

Other Devices by Eusa Pharma (Uk) Limited

Related Devices (Code: LFD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.